About This clinical research study
MAC Clinical Research is currently conducting a trial to test a new oral medication for eczema. Eczema, or atopic dermatitis, is a chronic inflammatory skin disorder and is the most common form of the condition, affecting up to 20% of the general population.
The purpose of this trial is to test how well study medication, EDP1867, works for the symptoms of eczema, and other long term immunoinflammatory conditions, and to see how safe and well tolerated it is.
Up to £1600
Clinics
Greater Manchester, Lancashire, Merseyside, South Staffordshire, South Yorkshire, Teesside and West Yorkshire
Therapy Area
Atopic Dermatitis
Gender and Age
Males and Females aged 18 - 65
A full description of the study will be given before you decide to take part, both over the phone and during an appointment at a MAC clinic. This will include you receiving the full patient information sheet (PIS). Your GP will also be notified of your participation.
If you contact us, it does not mean you have to decide at that point whether to participate.
If you do decide to participate you are free to withdraw at any time.
The study will last approximately 14 weeks and consist of 12 outpatient visits at either our Greater Manchester, Merseyside, West Yorkshire, Lancashire, South Staffordshire, South Yorkshire or Teesside clinics.
If the study medication is effective you may benefit from an improvement in your disease, but there is no guarantee. It is possible that you may not personally benefit from your participation in this study. However, by taking part, you will provide new information that may benefit other patients in the future.
Reimbursement: Up to £1600
Key Inclusion Criteria
- Male or female aged 18 – 65
- Diagnosis of eczema for at least the 6 months
- BMI 18 – 35 kg/m2
Key Exclusion Criteria
- Use of anti-inflammatory medications (such as ibuprofen) during the trial
- Use of topical medications that could affect eczema (for example steroid cream) two weeks prior and during the trial
Other eligibility criteria will apply. Please contact MAC for more information.
Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the participants’ treating physician.
ABOUT CLINICAL RESEARCH STUDIES
Clinical research studies are performed as a way of bringing about progress in medicine and research. Clinical research studies make it possible to scientifically assess the properties of a drug, to demonstrate the effectiveness and safety of a treatment or a medical device, or to learn more about a disease and methods to diagnose and monitor it.
If the study is successful, it may be an important step towards developing a promising new treatment.
MAC Clinical Research is conducting a trial to evaluate a potential new treatment for eczema.
If you would like more information, please fill in the form below and we will be in touch…
Alternatively, please call our recruitment team on freephone 0800 633 5507.
Know someone who may be interested in taking part? Share this page here:
